Linked Life Data

17024483

Source:http://linkedlifedata.com/resource/pubmed/id/17024483

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-10-30
pubmed:abstractText
Imatinib mesylate showed a sustained objective response in patients with advanced gastrointestinal stromal tumors (GISTs) since its introduction in 2001. Here we reported genetic changes during imatinib mesylate treatment especially when the patient had partial response or stationary disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1435-2443
pubmed:author
pubmed:issnType
Print
pubmed:volume
391
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
615-21
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Genetic changes in advanced gastrointestinal stromal tumor (GIST) patients during imatinib mesylate treatment.
pubmed:affiliation
Department of Surgery, Chang Gung Memorial Hospital, 5, Fu-Hsing Street, Kwei-Shan, Taoyuan, Taiwan, ycn@adm.cgmh.org.tw
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't